Literature DB >> 28269776

Amyloid-Related Imaging Abnormalities in an Aged Squirrel Monkey with Cerebral Amyloid Angiopathy.

Eric Heuer1,2, Jessica Jacobs2, Rebecca Du1, Silun Wang1, Orion P Keifer1, Amarallys F Cintron1, Jeromy Dooyema1, Yuguang Meng1, Xiaodong Zhang1, Lary C Walker1,3.   

Abstract

Amyloid-related imaging abnormalities (ARIA) in magnetic resonance imaging scans have emerged as indicators of potentially serious side effects in clinical trials of therapeutics for Alzheimer's disease. These anomalies include an edematous type (ARIA-E) that appears as hyperintense (bright) regions by T2-weighted MRI, and a type characterized by the deposition of hemosiderin (ARIA-H) that elicits a hypointense signal, especially in T2* susceptibility weighted images. ARIA in general has been linked to the presence of amyloid-β (Aβ)-type cerebral amyloid angiopathy, an accumulation of misfolded Aβ protein in the vascular wall that impairs the integrity of brain blood vessels. However, the pathobiology of ARIA remains poorly understood, in part due to the absence of an animal model of the disorder that would enable a contemporaneous analysis of tissue integrity in the affected region. Here we describe both ARIA-E and ARIA-H in an aged squirrel monkey (Saimiri sciureus), a nonhuman primate model of naturally occurring cerebral amyloid angiopathy. Histopathologic examination of the anomalous region revealed reactive astrocytosis and microgliosis, infiltration of systemic inflammatory/immune cells, damage to axons and myelin, and hemosiderin deposition. The disruption of axons in particular suggests that ARIA-E could have functional consequences for affected regions. The squirrel monkey model can be useful for studying the pathogenesis and long-term effects of ARIA, and for testing the safety and efficacy of emerging therapies for Alzheimer's disease.

Entities:  

Keywords:  ARIA-E; ARIA-H; Alzheimer’s disease; amyloid-beta; amyloid-related imaging abnormalities; immunotherapy; inflammation; magnetic resonance imaging; vascular disease

Mesh:

Substances:

Year:  2017        PMID: 28269776      PMCID: PMC5624788          DOI: 10.3233/JAD-160981

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  53 in total

1.  Cerebral hemorrhage after passive anti-Abeta immunotherapy.

Authors:  M Pfeifer; S Boncristiano; L Bondolfi; A Stalder; T Deller; M Staufenbiel; P M Mathews; M Jucker
Journal:  Science       Date:  2002-11-15       Impact factor: 47.728

Review 2.  Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: recommendations from the Alzheimer's Association Research Roundtable Workgroup.

Authors:  Reisa A Sperling; Clifford R Jack; Sandra E Black; Matthew P Frosch; Steven M Greenberg; Bradley T Hyman; Philip Scheltens; Maria C Carrillo; William Thies; Martin M Bednar; Ronald S Black; H Robert Brashear; Michael Grundman; Eric R Siemers; Howard H Feldman; Rachel J Schindler
Journal:  Alzheimers Dement       Date:  2011-07       Impact factor: 21.566

3.  Cerebral beta-amyloid angiopathy in aged squirrel monkeys.

Authors:  H A Elfenbein; R F Rosen; S L Stephens; R C Switzer; Y Smith; J Pare; P D Mehta; R Warzok; L C Walker
Journal:  Histol Histopathol       Date:  2007-02       Impact factor: 2.303

Review 4.  Ischemic brain injury in cerebral amyloid angiopathy.

Authors:  Yael D Reijmer; Susanne J van Veluw; Steven M Greenberg
Journal:  J Cereb Blood Flow Metab       Date:  2016-01       Impact factor: 6.200

5.  Capillary and arterial cerebral amyloid angiopathy in Alzheimer's disease: defining the perivascular route for the elimination of amyloid beta from the human brain.

Authors:  S D Preston; P V Steart; A Wilkinson; J A R Nicoll; R O Weller
Journal:  Neuropathol Appl Neurobiol       Date:  2003-04       Impact factor: 8.090

6.  Course of cerebral amyloid angiopathy-related inflammation.

Authors:  C Kinnecom; M H Lev; L Wendell; E E Smith; J Rosand; M P Frosch; S M Greenberg
Journal:  Neurology       Date:  2007-04-24       Impact factor: 9.910

7.  Spontaneous ARIA (amyloid-related imaging abnormalities) and cerebral amyloid angiopathy related inflammation in presenilin 1-associated familial Alzheimer's disease.

Authors:  Natalie S Ryan; Tammaryn Lashley; Tamas Revesz; Kiran Dantu; Nick C Fox; Huw R Morris
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

Review 8.  Cerebral amyloid angiopathy: emerging concepts.

Authors:  Masahito Yamada
Journal:  J Stroke       Date:  2015-01-30       Impact factor: 6.967

Review 9.  Immunotherapy for Alzheimer's disease: hoops and hurdles.

Authors:  Cynthia A Lemere
Journal:  Mol Neurodegener       Date:  2013-10-22       Impact factor: 14.195

Review 10.  The amyloid hypothesis of Alzheimer's disease at 25 years.

Authors:  Dennis J Selkoe; John Hardy
Journal:  EMBO Mol Med       Date:  2016-06-01       Impact factor: 12.137

View more
  5 in total

1.  Effects of relocation on immunological and physiological measures in female squirrel monkeys (Saimiri boliviensis boliviensis).

Authors:  Pramod N Nehete; Bharti P Nehete; Greg K Wilkerson; Steve J Schapiro; Lawrence E Williams
Journal:  PLoS One       Date:  2021-02-26       Impact factor: 3.240

Review 2.  Studying Alzheimer disease, Parkinson disease, and amyotrophic lateral sclerosis with 7-T magnetic resonance.

Authors:  Emrah Düzel; Mauro Costagli; Graziella Donatelli; Oliver Speck; Mirco Cosottini
Journal:  Eur Radiol Exp       Date:  2021-08-26

Review 3.  A Review of the Current Mammalian Models of Alzheimer's Disease and Challenges That Need to Be Overcome.

Authors:  Natasha Elizabeth Mckean; Renee Robyn Handley; Russell Grant Snell
Journal:  Int J Mol Sci       Date:  2021-12-06       Impact factor: 5.923

4.  Class C CpG Oligodeoxynucleotide Immunomodulatory Response in Aged Squirrel Monkey (Saimiri Boliviensis Boliviensis).

Authors:  Pramod N Nehete; Lawrence E Williams; Sriram Chitta; Bharti P Nehete; Akash G Patel; Margish D Ramani; Thomas Wisniewski; Henrieta Scholtzova
Journal:  Front Aging Neurosci       Date:  2020-03-03       Impact factor: 5.750

Review 5.  Microglia in Aging and Alzheimer's Disease: A Comparative Species Review.

Authors:  Melissa K Edler; Isha Mhatre-Winters; Jason R Richardson
Journal:  Cells       Date:  2021-05-08       Impact factor: 6.600

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.